Last reviewed · How we verify

NCT06173830

Ultrasound-guided Radiofrequency Ablation of the Genicular Nerve Versus Physical Therapy for Chronic Knee Osteoarthritis

Status unknown NA Last updated 18 December 2023
What this trial tests

NA trial testing radiofrequency ablation in Chronic Knee Osteoarthritis in 68 participants. Status unknown.

Timeline
15 October 2023
Primary endpoint
15 January 2024
15 April 2024

Quick facts

Lead sponsorAnkara City Hospital Bilkent
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment68
Start date15 October 2023
Primary completion15 January 2024
Estimated completion15 April 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 45 to 70, any sex, with Chronic Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effects of conventional physiotherapy methods with ultrasound-guided radiofrequency ablation of the genicular nerve on pain and functional status in patients with stage 2-3 chronic knee osteoarthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of radiofrequency ablation

Trials testing the same drug.

Other recruiting trials for Chronic Knee Osteoarthritis

Currently open trials in the same condition.

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06173830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing